Chat with us, powered by LiveChat

Featured – News & Media

Vaidheeswaran Archana Recognized by Intel Developer Zone

Saama Research Engineer, Vaidheeswaran Archana, was recently interviewed by Intel Developer Zone about her work for Saama, technological challenges she has resolved, and her experiences as a woman working in technology. “The seed of discovery and constant innovation drives every technologist or researcher. For some, there is a single moment that changed their perspective of the…

Read More

Srini Anandakumar Published by Drug Development and Delivery

Drug Development and Delivery recently published an article written by Saama’s Senior Director of Clinical Analytics Innovation, Srini Anandakumar , on the topic of reducing clinical cost budget variations: “Data-driven decisions offer higher potential in controlling the schedule and cost drivers, thus enabling reduction in schedule and budget variance. This article explores an approach for how…

Read More

Director of Marketing Programs, Crystal Black, Featured in MRP Podcast

MRP recently invited Saama Director of Marketing Programs, Crystal Black , to participate in their Artificial Intelligence for B2B Marketing podcast, where they discussed what it means to use NLU (Natural Language Understanding) to capture data in the language of nurses and doctors and how that data can be turned into usable analytics. Listen to the full podcast…

Read More

Karim Damji and Nekzad Shroff Quoted by PharmExec.com

In this article on PharmExec.com, Nekzad Shroff   and Karim Damji   discuss the necessary steps for the pharma industry to adopt modernized technologies and strategies. Karim states in the article, “Pharma companies have been doing it the hard way for a very long time. The tools and technologies that are available to other industries have not been widely…

Read More

Reaching and Engaging Your Customers More Effectively on PM360

Taking a platform-based approach to business processes in the life sciences industry can deliver incredible results for biotech and pharma companies. Luke Stewart  recently wrote on this topic, revealing just a few things that become possible when using a modern clinical data analytics platform: “Pharma and biotech companies can understand the clinical and commercial journey of…

Read More

Senior VP of Clinical Innovations Amit Gulwadi Writes Article for GEN

Amit Gulwadi  writes in his article for GEN: “The contemporary approaches in the industry offer an interesting paradox of access to plethora of data coupled with advanced analytical techniques. However, those datasets live in silos, often in non-analyzable-ready formats denying the end user the ability to leverage advances in analytical techniques to get deep insights and to…

Read More

Saama SVP, Karim Damji, and Board Advisor, Dr. Rebecca Kush, write for Clinical Informatics News

“When one looks beyond these initial challenges, the very real—and not inconsequential—operational and commercial benefits that clinical data standards offer the life sciences industry become apparent. These opportunities can be leveraged to maximize business outcomes for pharma,  biotech, and academia in a number of areas, both in the short-term and long run.” Read Karim Damji …

Read More

The Giddy Hope of New Technologies on PM360

Karim Damji, Saama’s Senior Vice President of Marketing is quoted: “Such state-of-the-art platforms are a gateway to a new era of clinical development, one in which structured and unstructured data is integrated, curated, and animated in unprecedented fashion for actionable business insights that safely and effectively speed the development of new drugs. Increased efficiencies and cost…

Read More

Saama SVP for Marketing Karim Damji writes for PharmaExec.com

An essential defense strategy of the ancient times, moats have now transformed from a physical to a virtual form to suit today’s corporate castles. Karim Damji, Saama’s Senior Vice President of Marketing recently wrote on this very aspect of “Creating Defensible Data Analytics Moats for a Competitive Advantage” in his article for PharmaExec.com. Further in his…

Read More

Related Posts